These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1643820)

  • 81. Delafloxacin: a novel fluoroquinolone with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa.
    Ocheretyaner ER; Park TE
    Expert Rev Anti Infect Ther; 2018 Jul; 16(7):523-530. PubMed ID: 29911455
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Clinical experience with ofloxacin in the treatment of chronic respiratory tract disease aggravated by acute infection].
    Muraki N; Chen RM; Kakusaka I; Kuriyama T; Kanno H; Kikuchi N; Suzuki K; Yamagishi F; Yamamoto T; Watanabe S
    Jpn J Antibiot; 1988 Sep; 41(9):1231-6. PubMed ID: 3149326
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy.
    Jones ME; Karlowsky JA; Draghi DC; Thornsberry C; Sahm DF; Nathwani D
    Int J Antimicrob Agents; 2004 Mar; 23(3):240-6. PubMed ID: 15164964
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Oral ofloxacin therapy for lower respiratory tract infection.
    Gentry LO; Lipsky B; Farber MO; Tucker B; Rodriguez-Gomez G
    South Med J; 1992 Jan; 85(1):14-8. PubMed ID: 1734527
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Multicenter study of the clinical efficacy of imipenem/cilastatin for treatment of serious infections.
    Trumbore D; Pontzer R; Levison ME; Kaye D; Cynamon M; Liu C; Hinthorn DR; Tan JS; File TM
    Rev Infect Dis; 1985; 7 Suppl 3():S476-81. PubMed ID: 3931198
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Use of ofloxacin in open fractures and in the treatment of post-traumatic osteomyelitis.
    Ketterl R; Beckurts T; Stübinger B; Claudi B
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():159-66. PubMed ID: 3053576
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Efficacy and tolerability of intravenous ofloxacin. A French multicenter study of 273 patients].
    Leroy O; Beuscart C; Sivery B; Senneville E; Mouton Y
    Presse Med; 1989 Dec 16-23; 18(42):2050-4. PubMed ID: 2532345
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Characterization of the onset and consequences of pneumonia due to fluoroquinolone-susceptible or -resistant Pseudomonas aeruginosa.
    Paladino JA; Sunderlin JL; Forrest A; Schentag JJ
    J Antimicrob Chemother; 2003 Sep; 52(3):457-63. PubMed ID: 12888598
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group.
    McCarty JM; Richard G; Huck W; Tucker RM; Tosiello RL; Shan M; Heyd A; Echols RM
    Am J Med; 1999 Mar; 106(3):292-9. PubMed ID: 10190377
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Evaluation by Monte Carlo simulation of levofloxacin dosing for complicated urinary tract infections caused by Escherichia coli or Pseudomonas aeruginosa.
    Deguchi T; Seike K; Yasuda M; Matsumoto T
    J Infect Chemother; 2011 Oct; 17(5):726-30. PubMed ID: 21409530
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Oral ofloxacin therapy of Pseudomonas aeruginosa sepsis in mice after irradiation.
    Brook I; Ledney GD
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1387-9. PubMed ID: 2117418
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.
    Greenberg RN; Kennedy DJ; Reilly PM; Luppen KL; Weinandt WJ; Bollinger MR; Aguirre F; Kodesch F; Saeed AM
    Antimicrob Agents Chemother; 1987 Feb; 31(2):151-5. PubMed ID: 3566245
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Respiratory infections: clinical experiences with the new quinolones.
    Davies BI; Maesen FP
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S53-7. PubMed ID: 3438151
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Open, prospective study of the clinical efficacy of ciprofloxacin.
    Ramirez CA; Bran JL; Mejia CR; Garcia JF
    Antimicrob Agents Chemother; 1985 Jul; 28(1):128-32. PubMed ID: 2931046
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Treatment of respiratory tract infections with pefloxacin in critically ill patients hospitalized in a surgical intensive care unit.
    Boland DM; van Gestel WC; MacLaren DM; de Jong D
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S58-9. PubMed ID: 3325930
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Treatment of chronic osteomyelitis with ciprofloxacin.
    Stuyck J; Verbist L; Mulier JC
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S93-6. PubMed ID: 3438153
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Ofloxacin: a review.
    Smythe MA; Rybak MJ
    DICP; 1989 Nov; 23(11):839-46. PubMed ID: 2688325
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Ofloxacin-delivery system of a polyanhydride and polylactide blend used in the treatment of bone infection.
    Chen L; Wang H; Wang J; Chen M; Shang L
    J Biomed Mater Res B Appl Biomater; 2007 Nov; 83(2):589-95. PubMed ID: 17410574
    [TBL] [Abstract][Full Text] [Related]  

  • 99. High-pressure liquid chromatography and microbiological assay of serum ofloxacin levels in adults receiving intravenous and oral therapy for skin infections.
    Auten GM; Preheim LC; Sookpranee M; Bittner MJ; Sookpranee T; Vibhagool A
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2558-61. PubMed ID: 1810189
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Results of ofloxacin therapy in andrologic patients suffering from therapy-requiring asymptomatic infections.
    Andreessen R; Sudhoff F; Borgmann V; Nagel R
    Andrologia; 1993; 25(6):377-83. PubMed ID: 8279713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.